Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 2/20 | 0.33 |
| ▸ | CASP7 | P55210 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3900193 | 0.79 | TSHR (0.39) | TSHRESR1ESR2ALDH1A1CYP3A4 | |
| SCHEMBL7877395 | 0.79 | TSHR (0.47) | TSHRESR1ESR2ALDH1A1CYP3A4 | |
| SCHEMBL843029 | 0.73 | ESR1 (0.44) | TSHRESR1ESR2ALDH1A1SMN1; SMN2 | |
| SCHEMBL6858049 | 0.73 | ESR1 (0.44) | TSHRESR1ESR2ALDH1A1CASP1 | |
| SCHEMBL242095 | 0.69 | ALDH1A1 (0.40) | TSHRESR1ESR2ALDH1A1SMN1; SMN2 | |
| SCHEMBL464991 | 0.69 | ALDH1A1 (0.40) | TSHRESR1ESR2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8194001 | 0.69 | ESR1 (0.41) | TSHRESR1ESR2ALDH1A1CYP3A4 | |
| SCHEMBL3889075 | 0.67 | CA4 (0.38) | TSHRESR1ESR2ALDH1A1CASP1 | |
| SCHEMBL10280463 | 0.67 | TP53 (0.38) | ESR1ESR2ALDH1A1MAOARAB9A | |
| SCHEMBL3886644 | 0.67 | CA4 (0.38) | TSHRESR1ESR2ALDH1A1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746922-A2 | INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747282-A1 | ACTIVATABLE TYROSINE-PROTEIN KINASE MEMBRANE RECEPTOR (ROR) ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747283-A1 | TYROSINE-PROTEIN KINASE MEMBRANE RECEPTOR 1 (ROR1) ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-113647198-B | Polarizing plate | NITTO DENKO CORP. (JP) | 2026-05-26 | — | — | CN | claimed |
| CN-116194989-B | System and method for hierarchical audio source separation | MITSUBISHI ELECTRIC CORP. (JP) | 2026-05-26 | — | — | CN | claimed |
| CN-122050840-A | Prostate cancer multi-mode data analysis system based on cloud collaboration | 南通大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| US-20260099093-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN USING SAME, AND METHOD FOR PRODUCING POLYIMIDE FILM USING SAME | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-04-09 | — | — | US | claimed |
| WO-2026044352-A1 | TWO-PARTNER SECRETION SYSTEM BINDING COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2026-03-05 | — | — | WO | claimed |
| US-12510543-B2 | Prostate antigen standards and uses thereof | OPKO DIAGNOSTICS, LLC (US) | 2025-12-30 | — | — | US | claimed |
| WO-2025228813-A1 | METHOD OF STRATIFYING HAEMATURIA PATIENTS | RANDOX LABORATORIES LTD (GB) | 2025-11-06 | — | — | WO | claimed |
| EP-2074087-A2 | SYNTHESIS OF PYRROLIDINE COMPOUNDS | Wyeth (US) | 2009-07-01 | — | — | EP | claimed |
| US-20080188545-A1 | (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride monohydrate; cardiovascular disease; osteoporosis; inflammation of airway epithelium; disorders of alveolar tissue; bladder incontinence; impaired hearing; endothelial lesions | ZEALAND PHARMA A/S (DK) | 2008-08-07 | — | — | US | claimed |
| WO-2008079266-A2 | SYNTHESIS OF PYRROLIDINE COMPOUNDS | WYETH (US) | 2008-07-03 | — | — | WO | claimed |
| EP-1881955-A1 | BIS-AMINATION OF ARYL HALIDES | Boehringer Ingelheim International GmbH (DE) | 2008-01-30 | — | — | EP | claimed |
| WO-2006124283-A1 | BIS-AMINATION OF ARYL HALIDES | BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) | 2006-11-23 | — | — | WO | claimed |
| US-20060258888-A1 | Bis-Amination of Aryl Halides | BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) | 2006-11-16 | — | — | US | claimed |
| US-7129187-B2 | Low-temperature plasma-enhanced chemical vapor deposition of silicon-nitrogen-containing films | TOKYO ELECTRON LIMITED (JP) | 2006-10-31 | — | — | US | claimed |
| WO-2006019438-A2 | LOW-TEMPERATURE PLASMA-ENHANCED CHEMICAL VAPOR DEPOSITION OF SILICON-NITROGEN-CONTAINING FILMS | TOKYO ELECTRON LIMITED (JP) | 2006-02-23 | — | — | WO | claimed |
| US-20060014399-A1 | Low-temperature plasma-enhanced chemical vapor deposition of silicon-nitrogen-containing films | TOKYO ELECTRON LIMITED | 2006-01-19 | — | — | US | claimed |
| US-6365643-B1 | Photoinitiators for cationic curing | TH. GOLDSCHMIDT AG (DE) | 2002-04-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260099093-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN USING SAME, AND METHOD FOR PRODUCING POLYIMIDE FILM USING SAME | CD79B, ITGA1, PTK2 | TSHR 2388/4885ESR1 1779/4885ESR2 1941/4885 |
| US-20060258888-A1 | Bis-Amination of Aryl Halides | ABL1, AOC2, AADAC | TSHR 926/4885ESR1 3593/4885ESR2 1995/4885 |
| US-20080188545-A1 | (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride monohydrate; cardiovascular disease; osteoporosis; inflammation of airway epithelium; disorders of alveolar tissue; bladder incontinence; impaired hearing; endothelial lesions | GLS, COL2A1, MYOC | TSHR 4384/4885ESR1 1567/4885ESR2 291/4885 |
| US-12510543-B2 | Prostate antigen standards and uses thereof | KLK3, KLK4, KLK2 | TSHR 4205/4885ESR1 722/4885ESR2 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.